| Literature DB >> 28613127 |
Torunn Bjerve Eide1, Jørund Straand1, Cecilia Björkelund2, Elise Kosunen3,4, Ofeigur Thorgeirsson5, Peter Vedsted6, Elin Olaug Rosvold1.
Abstract
OBJECTIVE: We aim to describe medical services provided by Nordic general practitioners (GPs), and to explore possible differences between the countries. DESIGN ANDEntities:
Keywords: General practice; Nordic countries; Organisation and Administration; QUALICOPC; diagnosis; equipment; health services; procedures
Mesh:
Year: 2017 PMID: 28613127 PMCID: PMC5499315 DOI: 10.1080/02813432.2017.1333323
Source DB: PubMed Journal: Scand J Prim Health Care ISSN: 0281-3432 Impact factor: 2.581
Organisation of general practice in the Nordic countries
| GP employment | Patient affiliation | Patient co-payment | Gate-keeping | |
|---|---|---|---|---|
| Norway | Mostly self-employed. Receive a combination of capitation fee and fee-for- service | Individual patient list system. All inhabitants are assigned to or choose a regular GP | Co-payment for adults ≥16 years | For all specialities |
| Sweden | Mostly employees in public (60%) or private health centres | All patients can register with a primary care centre (some centres offer registering with a specific GP) | Co-payment for adults ≥20 years | No |
| Denmark | Mostly self-employed. Receive a combination of capitation fee and fee-for- service | Patients listed with a general practice. 1% are not listed (group 2-insured) | No co-payment (group 2-insured pay part of the fee and have free choice of GP) | For most specialities. Patients can contact ophthalmologists and ear-nose-throat specialists directly |
| Finland | Mostly employees in public/private health centres or in occupational health care | Patient affiliation with public health centres or occupational health care centres. Partly subsidised private services also available | Co-payment for adults ≥18 years in public health centres, variations between municipalities. No co-payment in occupational health care | Referral is needed for specialist consultations through the public health system. Self-paying patients can contact all private specialists directly |
| Iceland | Mostly employees in public health centres | Patient affiliation with health centres | Co-payment for adults ≥18 years. Reduced co-payment >67 years | No |
Information from the Nordic co-operation www.norden.org/en/fakta-om-norden-1/the-nordic-countries-the-faroe-islands-greenland-and-aaland (January 2017).
Demographics of participating GPs in the Nordic part of the QUALICOPC study.
| Norway | Denmark | Sweden | Finland | Iceland | |
|---|---|---|---|---|---|
| Total | 198 | 212 | 97 | 288 | 80 |
| Female (%) | 39 | 43 | 55 | 71 | 28 |
| Age mean (range) | 45.7 (28–69) | 53.1 (35–76) | 52 (34–69) | 45 (25–70) | 54.5 (33–68) |
| Practices with distance to hospital >20 km (%) | 28 | 20 | 33 | 32 | 12 |
| Share practice with other GPs (%) | 99 | 72 | 99 | 65 | 98 |
| Self-employed (%) | 93 | 99 | 14 | 5 | 9 |
| Number of consultations per day | 19 (2–30) | 23.8 (12–40) | 13 (7–25) | 12.7 (2–40) | 13.2 (7–25) |
| Duration of regular consultation in minutes. | 18.6 (10–30) | 14.3 (7–20) | 24.1 (15–30) | 23.9 (10–60) | 19.3 (10–30) |
Estimated by the GPs.
Medical equipment in GP practices in the Nordic countries.
| Norway, | Sweden, | Denmark, | Finland, | Iceland, | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Equipment | % | % | % | % | % | |||||
| Hemoglobinometer | 195 | 98.5 | 95 | 97.9 | 201 | 94.8 | 235 | 82.7 | 68 | 85.0 |
| Blood glucose test | 197 | 99.5 | 93 | 95.9 | 205 | 96.7 | 274 | 96.5 | 75 | 93.8 |
| Cholesterol meter | 19 | 9.6 | 31 | 32.0 | 8 | 3.8 | 108 | 38.0 | 19 | 23.8 |
| Blood cell counter | 81 | 40.9 | 33 | 34.0 | 36 | 17.0 | 106 | 37.3 | 19 | 23.8 |
| Ophthalmoscope | 197 | 99.5 | 79 | 81.4 | 131 | 61.8 | 275 | 96.8 | 61 | 76.3 |
| Proctoscope | 153 | 77.3 | 97 | 100.0 | 76 | 35.8 | 261 | 91.9 | 42 | 52.5 |
| Otoscope | 198 | 100.0 | 96 | 99.0 | 210 | 99.1 | 277 | 97.5 | 74 | 92.5 |
| Gastroscope | 2 | 1.0 | 0 | 0.0 | 1 | 0.5 | 83 | 29.2 | 1 | 1.3 |
| Sigmoidoscope | 7 | 3.5 | 5 | 5.2 | 0 | 0.0 | 83 | 29.2 | 11 | 13.8 |
| X-ray | 11 | 5.6 | 3 | 3.1 | 0 | 0.0 | 178 | 62.7 | 8 | 10.0 |
| Ultrasound | 33 | 16.7 | 4 | 4.1 | 24 | 11.3 | 164 | 57.7 | 10 | 12.5 |
| Microscope | 125 | 63.1 | 61 | 62.9 | 153 | 72.2 | 64 | 22.5 | 58 | 72.5 |
| Audiometer | 89 | 44.9 | 71 | 73.2 | 118 | 55.7 | 234 | 82.4 | 73 | 91.3 |
| Bicycle ergometer | 4 | 2.0 | 7 | 7.2 | 1 | 0.5 | 88 | 31.0 | 6 | 7.5 |
| Eye tonometer | 160 | 80.8 | 36 | 37.1 | 3 | 1.4 | 259 | 91.2 | 36 | 45.0 |
| Peak flow meter | 161 | 81.3 | 94 | 96.9 | 204 | 96.2 | 280 | 98.6 | 67 | 83.8 |
| Spirometer | 197 | 99.5 | 95 | 97.9 | 206 | 97.2 | 188 | 66.2 | 79 | 98.8 |
| Electrocardiograph | 196 | 99 | 97 | 100.0 | 175 | 82.5 | 270 | 95.1 | 80 | 100.0 |
| Blood pressure monitor | 197 | 99.5 | 96 | 99.0 | 209 | 98.6 | 283 | 99.6 | 80 | 100.0 |
| Infusion set | 116 | 58.6 | 64 | 66.0 | 86 | 40.6 | 253 | 89.1 | 71 | 88.8 |
| Doctor’s bag | 167 | 84.3 | 94 | 96.9 | 208 | 98.1 | 180 | 63.4 | 78 | 97.5 |
| Urine catheter | 179 | 90.4 | 91 | 93.8 | 186 | 87.7 | 266 | 93.7 | 61 | 76.3 |
| Coagulometer | 134 | 67.7 | 60 | 61.9 | 157 | 74.1 | 76 | 26.8 | 3 | 3.8 |
| Set for minor surgery | 194 | 98.0 | 95 | 97.9 | 206 | 97.2 | 269 | 94.7 | 72 | 90.0 |
| Suture set | 195 | 98.5 | 96 | 99.0 | 210 | 99.1 | 278 | 97.9 | 77 | 96.3 |
| Defibrillator | 129 | 65.2 | 94 | 96.9 | 79 | 37.3 | 269 | 95.7 | 77 | 96.3 |
| Disposable syringes | 195 | 98.5 | 94 | 96.9 | 210 | 99.1 | 279 | 98.2 | 80 | 100.0 |
| Disposable gloves | 198 | 100.0 | 96 | 99.0 | 211 | 99.5 | 280 | 98.6 | 80 | 100.0 |
| Refrigerator for medicines | 198 | 100.0 | 96 | 99.0 | 212 | 100.0 | 279 | 98.2 | 79 | 98.8 |
| Resuscitation equipment | 166 | 83.8 | 84 | 86.6 | 193 | 91.0 | 270 | 95.1 | 76 | 95.0 |
Question: please tick the equipment used in your practice by yourself or your staff.
Number and valid percentages (95% CI) of GPs who reported that they usually or always performed the listed procedures, or were involved in treatment/follow-up of the listed diagnoses.
| Norway, | Sweden, | Denmark, | Finland, | Iceland, | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | ||||||
| Procedures | |||||||||||||||
| Wedge resection | 127 | 64.1 | 57–71 | 91 | 94.8 | 91–99 | 36 | 17.2 | 12–22 | 257 | 91.5 | 89–95 | 69 | 86.3 | 78–94 |
| Wound suturing | 186 | 94.4 | 91–97 | 95 | 99.0 | 97–100 | 141 | 66.8 | 61–73 | 258 | 91.8 | 89–95 | 60 | 75.0 | 78–94 |
| Removal sebaceous cyst | 144 | 73.1 | 67–79 | 84 | 87.5 | 81–95 | 118 | 55.9 | 49–63 | 226 | 80.4 | 75–85 | 52 | 66.7 | 57–77 |
| Excision wart | 163 | 82.3 | 77–87 | 30 | 31.9 | 23–41 | 135 | 64.0 | 58–70 | 175 | 62.9 | 57–69 | 64 | 81.0 | 72–90 |
| Insertion IUD | 177 | 89.8 | 86–94 | 19 | 19.8 | 12–28 | 182 | 86.3 | 81–91 | 195 | 69.6 | 65–75 | 10 | 12.5 | 6–20 |
| Fundoscopy | 151 | 76.3 | 70–82 | 53 | 55.8 | 46–66 | 10 | 4.7 | 2–8 | 206 | 73.3 | 68–78 | 21 | 26.3 | 16–36 |
| Joint injection | 109 | 55.1 | 48–62 | 87 | 90.6 | 85–97 | 106 | 50.2 | 43–57 | 267 | 95.7 | 94–98 | 61 | 7.2 | 68–86 |
| Strapping ankle | 80 | 40.4 | 33–47 | 83 | 86.5 | 80–94 | 169 | 80.1 | 75–85 | 203 | 72.5 | 68–78 | 52 | 65.8 | 56–76 |
| Cryotherapy warts | 167 | 84.3 | 79–89 | 14 | 14.7 | 8–22 | 141 | 66.8 | 61–73 | 153 | 54.4 | 48–60 | 76 | 95.0 | 90–100 |
| IV infusion | 52 | 26.4 | 20–32 | 37 | 38.9 | 29–49 | 7 | 3.3 | 1–5 | 178 | 63.3 | 57–69 | 21 | 26.6 | 17–37 |
| Diagnoses | |||||||||||||||
| Bronchitis | 194 | 99.0 | 98–100 | 96 | 100.0 | NA | 209 | 99.1 | 98–100 | 269 | 95.4 | 92–98 | 77 | 96.3 | 92–100 |
| Pneumonia | 195 | 99.5 | 98–100 | 96 | 100.0 | NA | 212 | 100.0 | NE | 249 | 88.9 | 85–93 | 77 | 100.0 | NA |
| Myocardial Infarction | 172 | 87.8 | 83–93 | 78 | 81.3 | 73–89 | 163 | 76.9 | 71–83 | 205 | 73.0 | 68–78 | 38 | 47.5 | 37–59 |
| Heart failure | 183 | 93.4 | 89–97 | 94 | 98.9 | 97–100 | 199 | 94.3 | 91–97 | 266 | 94.3 | 91–97 | 57 | 71.3 | 61–81 |
| Rheumatoid arthritis | 195 | 99.0 | 98–100 | 68 | 70.8 | 62–80 | 139 | 65.6 | 60–72 | 230 | 81.6 | 77–87 | 45 | 56.3 | 45–67 |
| Parkinson’s disease | 153 | 78.1 | 72–84 | 58 | 61.1 | 51–71 | 134 | 63.5 | 58–70 | 185 | 65.8 | 61–71 | 25 | 31.3 | 21–41 |
| Diabetes type 2 | 197 | 100.0 | NA | 96 | 100.0 | NA | 210 | 100.0 | NA | 266 | 94.3 | 91–97 | 78 | 98.7 | 97–100 |
| Peptic ulcer | 183 | 93.4 | 91–97 | 92 | 95.8 | 92–100 | 203 | 95.8 | 93–99 | 239 | 84.8 | 81–89 | 66 | 82.5 | 75–91 |
| Disc herniation | 195 | 99.5 | 98–100 | 95 | 99.0 | 97–100 | 209 | 98.9 | 98–100 | 251 | 89.0 | 85–93 | 80 | 100.0 | NA |
| Depression | 195 | 99.0 | 98–100 | 95 | 99.0 | 97–100 | 210 | 99.1 | 98–100 | 259 | 91.8 | 89–95 | 79 | 98.8 | 97–100 |
| Hordeolum | 166 | 84.7 | 80–90 | 87 | 90.6 | 85–97 | 201 | 94.8 | 92–98 | 213 | 75.8 | 71–81 | 77 | 96.3 | 92–100 |
| Peritonsillar abscess | 117 | 60.3 | 53–67 | 59 | 61.5 | 52–72 | 167 | 78.8 | 74–84 | 179 | 63.5 | 58–70 | 22 | 27.8 | 18–38 |
NA: not applicable due to separation of the material.
Question: To what extent are the following activities carried out in your practice population by you (or your staff) and not by a medical specialist (practice population means: people who normally apply to you for primary medical care)?
Question: To what extent are you involved in the treatment and follow-up of patients in your practice population with the following diagnoses?
Associations (odds ratio (95% CI)) between country and treatment/follow-up of different diagnoses. Logistic regression adjusted for GP sex, age, number of consultations per day and distance to hospital.
| Model | Bronchitis | Pneumonia | Myocardial Infarction | Heart failure | Rheumatoid arthritis | Parkinson’s disease | Diabetes type 2 | Peptic ulcer | Disc herniation | Depression | Hordeolum | Peritonsillar abscess |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Ref Norway | ||||||||||||
| Sweden | NA | NA | 0.8 (0.4–1.6) | 9.2 (1.1–75.1) | 0.5 (0.3–1.0) | NA | 1.9 (0.6–6.4) | 0.5 (0.03–9.1) | 0.9 (0.1–10.6) | 1.8 (0.08–4.2) | 1.1 (0.7–2.0) | |
| Denmark | 0.9 (0.1–7.1) | NA | 0.6 (0.3–1.0) | 0.9 (0.4–2.1) | NA | 1.1 (0.4–2.8) | 0.4 (0.04–4.0) | 1.2 (0.2–8.8) | ||||
| Finland | 0.4 (0.1–2.1) | 0.1 (0.01–0.9) | 2.0 (0.8–4.7) | 0.7 (0.4–1.2) | 0.7 (0.5–1.2) | NA | 0.6 (0.3–1.3) | 0.6 (0.4–1.1) | 1.3 (0.8–2.0) | |||
| Iceland | 0.7 (0.1–6.2) | NA | NA | 0.3 (0.1–0.9) | NA | 0.7 (0.1–7.9) | 4.4 (1.3–15.6) | |||||
| 2. Ref Finland | ||||||||||||
| Sweden | NA | NA | 1.7 (0.9–3.1) | 4.7 (0.6–36.4) | 0.7 (0.4–1.2) | NA | 3.3 (1.1–9.5) | 12.2 (1.6–92.3) | 8.9 (1.2–68.5) | 0.9 (0.6–1.5) | ||
| Denmark | 2.3 (0.3–16.1) | NA | 1.3 (0.7–2.3) | 0.5 (0.2–1.3) | 0.7 (0.4–1.2) | NA | 1.9 (0.7–5.2) | |||||
| Iceland | 2.0 (0.4–9.8) | NA | 4.7 (0.5–40.1) | 0.6 (0.3–1.2) | NA | 6.6 (0.8–53.2) | ||||||
| 3. Ref Denmark | ||||||||||||
| Sweden | NA | NA | 1.4 (0.7–2.8) | 10.5 (1.2–92.1) | 1.6 (0.8–3.1) | 1.1 (0.6–2.0) | NA | 1.7 (0.4–6.6) | 1.4 (0.1–15.3) | 0.8 (0.1–10.1) | 0.6 (0.2–1.7) | |
| Iceland | 0.9 (0.1–7.8) | NA | 0.8 (0.4–1.5) | NA | 0.3 (0.1–0.9) | NA | 0.6 (0.1–7.4) | 1.5 (0.4–6.0) | ||||
| 4. Ref Sweden | ||||||||||||
| Iceland | NA | NA | 0.5 (0.3–0.9) | NA | NA | 0.7 (0.04–12.3) | 2.5 (0.6–9.5) |
Bold figures: p ≤ 0.0125. NA: not applicable due to separation of the material.
Comparison with Norway in model 1.
Comparisons with Norway and Finland in models 1 and 2, respectively.
Comparisons with Norway, Finland and Denmark in models 1, 2 and 3, respectively.
Associations (odds ratio (95% CI)) between country and procedures performed by the GPs or their staff. Logistic regression adjusted for sex, age, number of consultations per day and distance to hospital.
| Model | Suture | IUD | Fundoscopy | Joint injection | Strapping of ankle | Cryotherapy of warts | Intravenous infusion | Wedge resection toenail | Removal of sebaceous cyst | Wart excision |
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Ref Norway | ||||||||||
| Sweden | NA | 1.6 (0.9–3.0) | ||||||||
| Denmark | 0.1 (0.0–0.2) | 0.6 (0.3–1.2) | 0.7 (0.4–1.1) | |||||||
| Finland | 1.2 (0.5–2.8) | 1.1 (0.7–1.8) | 0.7 (0.4–1.2) | |||||||
| Iceland | 0.3 (0.1–0.8) | 1.1 (0.6–2.2) | 0.9 (0.5–1.8) | 1.5 (0.7–3.1) | ||||||
| 2. Ref Finland | ||||||||||
| Sweden | NA | 0.4 (0.1–0.9) | 2.2 (1.1–4.3) | 1.4 (0.5–3.8) | 1.5 (0.8–3.1) | |||||
| Denmark | 1.0 (0.6–1.8) | 1.3 (0.8–2.2) | ||||||||
| Iceland | 0.6 (0.3–1.1) | 0.5 (0.2–1.0) | 2.1 (1.1–4.1) | |||||||
| 3. Ref Denmark | ||||||||||
| Sweden | NA | 2.2 (1.0–4.9) | 0.6 (0.3–1.1) | |||||||
| Iceland | 0.6 (0.3–1.2) | |||||||||
| 4. Ref Sweden | ||||||||||
| Iceland | NA | 0.9 (0.4–2.1) | 0.4 (0.2–0.9) | 0.7 (0.3–1.4) | 0.3 (0.1–1.0) |
Bold figures: p < 0.0125. NA: not applicable due to separation of the material.
Comparison with Norway in model 1.
Comparisons with Norway and Finland in models 1 and 2, respectively.
Comparisons with Norway, Finland and Denmark in models 1, 2 and 3, respectively.